Combination Therapy With Plasmapheresis, IVIG, and Rituximab Provides Benefit in the Management of Early Antibody Mediated Rejection in Lung Transplant in a Pilot Cohort
Year: 2013
Type: article
Source: CHEST Journal
Institution: Brigham and Women's Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2052913703
